CA2585287A1 - Melanocortin receptor binding mimetibodies, compositions, methods and uses - Google Patents

Melanocortin receptor binding mimetibodies, compositions, methods and uses Download PDF

Info

Publication number
CA2585287A1
CA2585287A1 CA002585287A CA2585287A CA2585287A1 CA 2585287 A1 CA2585287 A1 CA 2585287A1 CA 002585287 A CA002585287 A CA 002585287A CA 2585287 A CA2585287 A CA 2585287A CA 2585287 A1 CA2585287 A1 CA 2585287A1
Authority
CA
Canada
Prior art keywords
seq
polypeptide
cell
alpha
mimetibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002585287A
Other languages
English (en)
French (fr)
Inventor
Mark Cunningham
Vedrana Stojanovic-Susulic
Karyn O'neil
Chichi Huang
Jeffrey Luo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2585287A1 publication Critical patent/CA2585287A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002585287A 2004-10-25 2005-10-25 Melanocortin receptor binding mimetibodies, compositions, methods and uses Abandoned CA2585287A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62196004P 2004-10-25 2004-10-25
US60/621,960 2004-10-25
PCT/US2005/038431 WO2006047535A2 (en) 2004-10-25 2005-10-25 Melanocortin receptor binding mimetibodies, compositions, methods and uses

Publications (1)

Publication Number Publication Date
CA2585287A1 true CA2585287A1 (en) 2006-05-04

Family

ID=36228385

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002585287A Abandoned CA2585287A1 (en) 2004-10-25 2005-10-25 Melanocortin receptor binding mimetibodies, compositions, methods and uses

Country Status (28)

Country Link
US (1) US20060105951A1 (cg-RX-API-DMAC7.html)
EP (1) EP1812046B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008517605A (cg-RX-API-DMAC7.html)
KR (1) KR101255140B1 (cg-RX-API-DMAC7.html)
CN (1) CN101437540B (cg-RX-API-DMAC7.html)
AT (1) ATE501731T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005299440B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0518411A2 (cg-RX-API-DMAC7.html)
CA (1) CA2585287A1 (cg-RX-API-DMAC7.html)
CY (1) CY1111486T1 (cg-RX-API-DMAC7.html)
DE (1) DE602005026970D1 (cg-RX-API-DMAC7.html)
DK (1) DK1812046T3 (cg-RX-API-DMAC7.html)
EA (1) EA200700944A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP077416A (cg-RX-API-DMAC7.html)
ES (1) ES2363023T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20110405T1 (cg-RX-API-DMAC7.html)
IL (1) IL182683A0 (cg-RX-API-DMAC7.html)
MA (1) MA28943B1 (cg-RX-API-DMAC7.html)
ME (1) ME01234B (cg-RX-API-DMAC7.html)
MX (1) MX2007004974A (cg-RX-API-DMAC7.html)
NO (1) NO20072499L (cg-RX-API-DMAC7.html)
PL (1) PL1812046T3 (cg-RX-API-DMAC7.html)
PT (1) PT1812046E (cg-RX-API-DMAC7.html)
RS (1) RS51789B (cg-RX-API-DMAC7.html)
SI (1) SI1812046T1 (cg-RX-API-DMAC7.html)
TN (1) TNSN07157A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006047535A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200704260B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910101B2 (en) * 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) * 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
AR072072A1 (es) * 2008-06-09 2010-08-04 Palatin Technologies Inc Peptidos especificos del receptor de melanocortina para el tratamiento de la obesidad / 669
EP2300036B1 (en) 2008-06-09 2017-04-05 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
US8614185B2 (en) * 2009-05-04 2013-12-24 Centocor Ortho Biotech Inc. Fusion proteins of alpha-MSH derivatives and Fc
BRPI1009644B1 (pt) 2009-06-08 2022-02-08 Palatin Technologies, Inc Peptídeo cíclico ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica e uso da composição farmacêutica
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
WO2010144341A2 (en) 2009-06-08 2010-12-16 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
EP2504351A4 (en) 2009-11-23 2013-10-30 Palatin Technologies Inc MELANOCORTIN-1 RECEPTOR-SPECIFIC LINEAR PEPTIDE
AU2010321738B2 (en) 2009-11-23 2016-07-14 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides
JP2020141710A (ja) * 2011-07-06 2020-09-10 ゲンマブ エー/エス 抗体重鎖のc末端の修飾による補体依存性細胞傷害の調節
WO2020177627A1 (zh) * 2019-03-02 2020-09-10 上海一宸医药科技有限公司 一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01005818A (es) * 1998-12-09 2003-07-21 Eleanor Rooseveltl Inst Composicion y metodo para la regulacion del peso del cuerpo y condiciones asociadas.
WO2002006316A2 (en) * 2000-07-14 2002-01-24 Zycos, Inc. Alpha-msh related compounds and methods of use
WO2004002417A2 (en) * 2002-06-28 2004-01-08 Centocor, Inc. Mammalian ch1 deleted mimetibodies, compositions, methods and uses
US7241733B2 (en) * 2002-06-28 2007-07-10 Centocor, Inc. Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
EP1750754A4 (en) * 2004-03-31 2010-09-22 Centocor Ortho Biotech Inc HUMAN GLP-1 MIMETIC BODIES, COMPOSITIONS, METHODS AND USES

Also Published As

Publication number Publication date
WO2006047535A2 (en) 2006-05-04
ATE501731T1 (de) 2011-04-15
HK1106445A1 (en) 2008-03-14
EP1812046B1 (en) 2011-03-16
PT1812046E (pt) 2011-06-28
SI1812046T1 (sl) 2011-06-30
ZA200704260B (en) 2009-03-25
US20060105951A1 (en) 2006-05-18
WO2006047535A3 (en) 2008-09-04
PL1812046T3 (pl) 2011-08-31
IL182683A0 (en) 2007-09-20
RS51789B (sr) 2011-12-31
BRPI0518411A2 (pt) 2008-11-18
KR101255140B1 (ko) 2013-04-22
EA200700944A1 (ru) 2008-04-28
CY1111486T1 (el) 2015-08-05
HRP20110405T1 (hr) 2011-06-30
AU2005299440B2 (en) 2011-12-15
DK1812046T3 (da) 2011-06-06
CN101437540B (zh) 2012-12-19
CN101437540A (zh) 2009-05-20
NO20072499L (no) 2007-07-16
ECSP077416A (es) 2007-05-30
JP2008517605A (ja) 2008-05-29
MA28943B1 (fr) 2007-10-01
ME01234B (me) 2013-06-20
KR20070085416A (ko) 2007-08-27
DE602005026970D1 (de) 2011-04-28
EP1812046A2 (en) 2007-08-01
MX2007004974A (es) 2007-10-17
TNSN07157A1 (en) 2008-11-21
EP1812046A4 (en) 2009-11-11
ES2363023T3 (es) 2011-07-19
AU2005299440A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
EP2214690B1 (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
US8043616B2 (en) sRAGE mimetibody, compositions, methods and uses
US8722615B2 (en) Compositions and methods for increasing serum half-life
US20140051834A1 (en) Incretin Receptor Ligand Polypeptide Fc-Region Fusion Polypeptides And Conjugates With Altered Fc-Effector Function
JP2019001793A (ja) 免疫グロブリンFc変異体
CN113271972B (zh) 用于替代IVIG的多聚体杂交Fc蛋白
AU2005299440B2 (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
CN102875683B (zh) 长效重组人生长激素的Fc融合蛋白
EP1792626B1 (en) Treatment of obesity with alpha-MSH mimetibodies
WO2023125881A1 (zh) Glp-1和gdf15的融合蛋白及其用途
HK1106445B (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
CA2704446A1 (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
WO2023025129A1 (zh) Gdf15融合蛋白及其用途
HK1208880B (en) Method for producing monomeric and multimeric molecules and uses thereof

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued